Stifel on Globus Medical (GMED) Buying NVRO: 'A Bit of a Head Scratcher'
Tweet Send to a Friend
Stifel analyst Mathew Blackman reiterated a Buy rating and $92.00 price target on Globus Medical (NYSE: GMED).The analyst comments "In ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
